Global mRNA Vaccine Market Insights, Forecast to 2025

Global mRNA Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 mRNA Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global mRNA Vaccine Market Size Growth Rate by Product
1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
1.4.3 Individualized Cancer Treatment MRNA Vaccine
1.4.4 Infectious Disease Treatment MRNA Vaccine
1.4.5 Infection Prevention MRNA Vaccine
1.5 Market by End User
1.5.1 Global mRNA Vaccine Market Size Growth Rate by End User
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global mRNA Vaccine Market Size
2.1.1 Global mRNA Vaccine Revenue 2014-2025
2.1.2 Global mRNA Vaccine Sales 2014-2025
2.2 mRNA Vaccine Growth Rate by Regions
2.2.1 Global mRNA Vaccine Sales by Regions
2.2.2 Global mRNA Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 mRNA Vaccine Sales by Manufacturers
3.1.1 mRNA Vaccine Sales by Manufacturers
3.1.2 mRNA Vaccine Sales Market Share by Manufacturers
3.1.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 mRNA Vaccine Revenue by Manufacturers
3.2.1 mRNA Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 mRNA Vaccine Price by Manufacturers
3.4 mRNA Vaccine Manufacturing Base Distribution, Product Types
3.4.1 mRNA Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers mRNA Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into mRNA Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global mRNA Vaccine Sales by Product
4.2 Global mRNA Vaccine Revenue by Product
4.3 mRNA Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global mRNA Vaccine Breakdown Data by End User
6 North America
6.1 North America mRNA Vaccine by Countries
6.1.1 North America mRNA Vaccine Sales by Countries
6.1.2 North America mRNA Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America mRNA Vaccine by Product
6.3 North America mRNA Vaccine by End User
7 Europe
7.1 Europe mRNA Vaccine by Countries
7.1.1 Europe mRNA Vaccine Sales by Countries
7.1.2 Europe mRNA Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe mRNA Vaccine by Product
7.3 Europe mRNA Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific mRNA Vaccine by Countries
8.1.1 Asia Pacific mRNA Vaccine Sales by Countries
8.1.2 Asia Pacific mRNA Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific mRNA Vaccine by Product
8.3 Asia Pacific mRNA Vaccine by End User
9 Central & South America
9.1 Central & South America mRNA Vaccine by Countries
9.1.1 Central & South America mRNA Vaccine Sales by Countries
9.1.2 Central & South America mRNA Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America mRNA Vaccine by Product
9.3 Central & South America mRNA Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccine by Countries
10.1.1 Middle East and Africa mRNA Vaccine Sales by Countries
10.1.2 Middle East and Africa mRNA Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa mRNA Vaccine by Product
10.3 Middle East and Africa mRNA Vaccine by End User
11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Company Business Overview
11.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 Company Business Overview
11.2.3 CureVac mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CureVac mRNA Vaccine Products Offered
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Company Business Overview
11.3.3 Translate Bio mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Translate Bio mRNA Vaccine Products Offered
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 Company Business Overview
11.4.3 BioNTech mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BioNTech mRNA Vaccine Products Offered
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sangamo Therapeutics mRNA Vaccine Products Offered
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Company Business Overview
11.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Argos Therapeutics mRNA Vaccine Products Offered
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 Company Business Overview
11.7.3 In-Cell-Art mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 In-Cell-Art mRNA Vaccine Products Offered
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 Company Business Overview
11.8.3 eTheRNA mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 eTheRNA mRNA Vaccine Products Offered
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Company Business Overview
11.9.3 Ethris mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ethris mRNA Vaccine Products Offered
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Company Business Overview
11.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Tiba Biotechnology mRNA Vaccine Products Offered
11.10.5 Tiba Biotechnology Recent Development
12 Future Forecast
12.1 mRNA Vaccine Market Forecast by Regions
12.1.1 Global mRNA Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global mRNA Vaccine Revenue Forecast by Regions 2019-2025
12.2 mRNA Vaccine Market Forecast by Product
12.2.1 Global mRNA Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global mRNA Vaccine Revenue Forecast by Product 2019-2025
12.3 mRNA Vaccine Market Forecast by End User
12.4 North America mRNA Vaccine Forecast
12.5 Europe mRNA Vaccine Forecast
12.6 Asia Pacific mRNA Vaccine Forecast
12.7 Central & South America mRNA Vaccine Forecast
12.8 Middle East and Africa mRNA Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 mRNA Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure mRNA Vaccine Product Picture
Table mRNA Vaccine Market Segments
Table Key Manufacturers mRNA Vaccine Covered
Table Global mRNA Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global mRNA Vaccine Sales Market Share by Product 2014-2025
Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Figure Infection Prevention MRNA Vaccine Product Picture
Table Major Manufacturers of Infection Prevention MRNA Vaccine
Table Global mRNA Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Infectious Disease
Figure Cancer
Figure Other
Figure mRNA Vaccine Report Years Considered
Figure Global mRNA Vaccine Market Size 2014-2025 (Million US$)
Figure Global mRNA Vaccine Sales 2014-2025 (K Doses)
Table Global mRNA Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global mRNA Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global mRNA Vaccine Sales Market Share by Regions 2014-2019
Figure Global mRNA Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global mRNA Vaccine Sales Market Share by Regions
Table Global mRNA Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global mRNA Vaccine Revenue Market Share by Regions 2014-2019
Figure Global mRNA Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global mRNA Vaccine Revenue Market Share by Regions
Table Global mRNA Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global mRNA Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global mRNA Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table mRNA Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table mRNA Vaccine Revenue Share by Manufacturers (2014-2019)
Figure mRNA Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers mRNA Vaccine Price (2014-2019) (USD/Dose)
Table mRNA Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers mRNA Vaccine Product Type
Table Date of International Manufacturers Enter into mRNA Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Global mRNA Vaccine Sales Share by Product (2014-2019)
Figure Global mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure Global mRNA Vaccine Sales Market Share by Product in 2018
Table Global mRNA Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global mRNA Vaccine Revenue Share by Product (2014-2019)
Figure Global mRNA Vaccine Revenue Market Share by Product (2014-2019)
Figure Global mRNA Vaccine Revenue Market Share by Product in 2018
Table mRNA Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Global mRNA Vaccine Sales Share by End User (2014-2019)
Figure Global Sales mRNA Vaccine Market Share by End User (2014-2019)
Figure Global Sales mRNA Vaccine Market Share by End User in 2018
Figure North America mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America mRNA Vaccine Sales Market Share by Countries
Table North America mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America mRNA Vaccine Revenue Market Share by Countries
Figure United States mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States mRNA Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table North America mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America mRNA Vaccine Market Share by Product
Table North America mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table North America mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America mRNA Vaccine Market Share by End User
Figure Europe mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe mRNA Vaccine Sales Market Share by Countries
Table Europe mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe mRNA Vaccine Revenue Market Share by Countries
Figure Germany mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe mRNA Vaccine Market Share by Product
Table Europe mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe mRNA Vaccine Market Share by End User
Figure Asia Pacific mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Sales Market Share by Countries
Table Asia Pacific mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Revenue Market Share by Countries
Figure China mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Market Share by Product
Table Asia Pacific mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Market Share by End User
Figure Central & South America mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Sales Market Share by Countries
Table Central & South America mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Revenue Market Share by Countries
Figure Brazil mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Market Share by Product
Table Central & South America mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Market Share by End User
Figure Middle East and Africa mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Sales Market Share by Countries
Table Middle East and Africa mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Revenue Market Share by Countries
Figure GCC Countries mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Market Share by Product
Table Middle East and Africa mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Market Share by End User
Table Moderna Therapeutics Company Details
Table Moderna Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Moderna Therapeutics Recent Development
Table CureVac Company Details
Table CureVac mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CureVac Recent Development
Table Translate Bio Company Details
Table Translate Bio mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Translate Bio Recent Development
Table BioNTech Company Details
Table BioNTech mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table BioNTech Recent Development
Table Sangamo Therapeutics Company Details
Table Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sangamo Therapeutics Recent Development
Table Argos Therapeutics Company Details
Table Argos Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Argos Therapeutics Recent Development
Table In-Cell-Art Company Details
Table In-Cell-Art mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table In-Cell-Art Recent Development
Table eTheRNA Company Details
Table eTheRNA mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table eTheRNA Recent Development
Table Ethris Company Details
Table Ethris mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Ethris Recent Development
Table Tiba Biotechnology Company Details
Table Tiba Biotechnology mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Tiba Biotechnology Recent Development
Table Global mRNA Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global mRNA Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global mRNA Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global mRNA Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global mRNA Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global mRNA Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global mRNA Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global mRNA Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global mRNA Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global mRNA Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table mRNA Vaccine Value Chain
Table mRNA Vaccine Customers List
Table mRNA Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs